Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

18.23 -0.83 (-4.35%)

Streaming Delayed Price Updated: 1:39 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	241,387
Open	19.02
Bid (Size)	18.22 (100)
Ask (Size)	18.24 (100)
Prev. Close	19.06
Today's Range	17.97 - 19.25
52wk Range	7.900 - 21.03
Shares Outstanding	49,471,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗

February 23, 2026

This healthcare firm runs a national network of surgical centers, specializing in outpatient procedures across key medical specialties.

Via The Motley Fool

Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround ↗

February 23, 2026

This fintech firm provides cloud-based digital banking solutions for U.S. financial institutions with a focus on subscription revenue.

Via The Motley Fool

Performance

YTD	+0.4%	+0.4%
1 Month	-7.7%	-7.7%
3 Month	-8.7%	-8.7%
6 Month	+32.1%	+32.1%
1 Year	+103.2%	+103.2%

More News

Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year ↗

February 23, 2026

Via The Motley Fool

Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗

February 11, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters ↗

February 23, 2026

Via The Motley Fool

Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗

February 22, 2026

Via The Motley Fool

Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗

February 22, 2026

Via The Motley Fool

Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗

February 22, 2026

Via The Motley Fool

Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗

February 22, 2026

Via The Motley Fool

Irenic Dumps Most Papa John's Shares ↗

February 22, 2026

Via The Motley Fool

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 26, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

January 23, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Tuesday. ↗

January 13, 2026

Via Chartmill

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗

December 07, 2025

Via The Motley Fool

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗

December 07, 2025

Via The Motley Fool

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗

December 07, 2025

Via The Motley Fool

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗

December 07, 2025

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Via Chartmill

Here's Why Shares in Theravance Biopharma Exploded Today ↗

November 11, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction ↗

November 10, 2025

Via Chartmill

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

October 21, 2025

Via Benzinga

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

October 21, 2025

Via Benzinga

Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy

October 16, 2025

From Theravance Biopharma

Via Business Wire

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?

Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.

What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?

Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?

The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market

What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?

The current price of Theravance Biopharma, Inc. - Ordinary Shares is 18.23

When was Theravance Biopharma, Inc. - Ordinary Shares last traded?

The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 02/26/26 01:39 PM ET

What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?

The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 901.86M

How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?

Theravance Biopharma, Inc. - Ordinary Shares has 902M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.